Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael D Hughes

Showing results (1-10 of 224) with videos related to

Pageof 23
Sort By:
The Journal of Infectious Diseases|August 10, 2006
Initial treatment of HIV infection: randomized trials with clinical end points are still neededMichael D Hughes
Controlled Clinical Trials|December 31, 2002
Evaluating surrogate endpointsMichael D Hughes
Statistical Methods in Medical Research|February 21, 2008
Practical issues arising in an exploratory analysis evaluating progression-free survival as a surrogate endpoint for overall survival in advanced colorectal cancerMichael D Hughes
Biometrics|February 12, 2008
A statistical framework for quantile equivalence clinical trials with application to pharmacokinetic studies that bridge from HIV-infected adults to childrenLixia Pei, Michael D Hughes
Statistics in Medicine|August 4, 2010
Assessing agreement in the timing of treatment initiation determined by repeated measurements of novel versus gold standard technologies with application to the monitoring of CD4 counts in HIV-infected patientsFarzad Noubary, Michael D Hughes
Journal of Acquired Immune Deficiency Syndromes (1999)|August 11, 2012
Factors affecting timing of antiretroviral treatment initiation based on monitoring CD4 countsFarzad Noubary, Michael D Hughes
Statistics in Medicine|February 1, 2020
Sample size estimation for stratified individual and cluster randomized trials with binary outcomesLee Kennedy-Shaffer, Michael D Hughes
The Journal of Infectious Diseases|May 9, 2008
The search for data on when to start treatment for HIV infectionMichael D Hughes, Heather R Ribaudo
The New England Journal of Medicine|April 27, 2007
Challenges in using observational studies to evaluate adverse effects of treatmentMichael D Hughes, Paige L Williams
Statistics in Medicine|January 15, 2016
Evaluating predictors of competing risk outcomes when censoring depends on time-dependent covariates, with application to safety and efficacy of HIV treatmentJudith J Lok, Michael D Hughes
Pageof 23

Showing results (1-10 of 224) with videos related to

Sort By:
Pageof 23
The Journal of Infectious Diseases|August 10, 2006
Initial treatment of HIV infection: randomized trials with clinical end points are still neededMichael D Hughes
Controlled Clinical Trials|December 31, 2002
Evaluating surrogate endpointsMichael D Hughes
Statistical Methods in Medical Research|February 21, 2008
Practical issues arising in an exploratory analysis evaluating progression-free survival as a surrogate endpoint for overall survival in advanced colorectal cancerMichael D Hughes
Biometrics|February 12, 2008
A statistical framework for quantile equivalence clinical trials with application to pharmacokinetic studies that bridge from HIV-infected adults to childrenLixia Pei, Michael D Hughes
Statistics in Medicine|August 4, 2010
Assessing agreement in the timing of treatment initiation determined by repeated measurements of novel versus gold standard technologies with application to the monitoring of CD4 counts in HIV-infected patientsFarzad Noubary, Michael D Hughes
Journal of Acquired Immune Deficiency Syndromes (1999)|August 11, 2012
Factors affecting timing of antiretroviral treatment initiation based on monitoring CD4 countsFarzad Noubary, Michael D Hughes
Statistics in Medicine|February 1, 2020
Sample size estimation for stratified individual and cluster randomized trials with binary outcomesLee Kennedy-Shaffer, Michael D Hughes
The Journal of Infectious Diseases|May 9, 2008
The search for data on when to start treatment for HIV infectionMichael D Hughes, Heather R Ribaudo
The New England Journal of Medicine|April 27, 2007
Challenges in using observational studies to evaluate adverse effects of treatmentMichael D Hughes, Paige L Williams
Statistics in Medicine|January 15, 2016
Evaluating predictors of competing risk outcomes when censoring depends on time-dependent covariates, with application to safety and efficacy of HIV treatmentJudith J Lok, Michael D Hughes
Pageof 23